AIP
THRX

Ameritas Investment Partners’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Ameritas Investment Partners’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-889
Closed -$3.6K – 3102
2023
Q4 		$3.6K Hold
889
– – ﹤0.01% 3015
2023
Q3 		$2.39K Hold
889
– – ﹤0.01% 3061
2023
Q2 		$8.29K Hold
889
– – ﹤0.01% 2954
2023
Q1 		$7.89K Hold
889
– – ﹤0.01% 2791
2022
Q4 		$9.78K Hold
889
– – ﹤0.01% 2811
2022
Q3 		$5K Hold
889
– – ﹤0.01% 2929
2022
Q2 		$4K Hold
889
– – ﹤0.01% 2995
2022
Q1 		$10K Hold
889
– – ﹤0.01% 2811
2021
Q4 		$11K Buy
+889
New +$13.4K ﹤0.01% 2883

Ameritas Investment Partners's THRX Position: Q1 2024 in Review

Ameritas Investment Partners sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 889 shares — an estimated $3.6K sold.

Ameritas Investment Partners first reported a position in THRX in Q4 2021 and held it in 9 quarters. The position peaked at $11K in Q4 2021. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

  • Ameritas Investment Partners reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 889 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $3.6K.
  • Ameritas Investment Partners first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Ameritas Investment Partners's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $11K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Ameritas Investment Partners's 13F filing for Q1 2024, filed 13 May 2024.